Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 488,668 | 244,674 | 29,076 | 24,043 | 22,526 |
| Marketable Securities | 70,773 | 27,263 | 37,737 | 62,106 | 47,825 |
| Receivables | 32,108 | 22,275 | 13,692 | 12,555 | 6,347 |
| Inventories | 8,456 | 10,145 | 9,587 | 5,395 | 1,571 |
| Income taxes - deferred | 9,601 | 26,860 | N/A | N/A | N/A |
| TOTAL | $617,620 | $337,045 | $95,267 | $109,489 | $79,599 |
| Non-Current Assets | |||||
| PPE Net | 7,055 | 8,340 | 8,237 | 1,070 | 698 |
| Investments And Advances | 6,961 | 4,080 | 11,079 | 53,644 | 6,537 |
| Intangibles | 72,361 | 82,521 | 25,078 | 0 | 0 |
| Other Non-Current Assets | 7,068 | 76,667 | 1,992 | 169 | 197 |
| TOTAL | $93,445 | $171,608 | $46,386 | $54,883 | $7,432 |
| Total Assets | $711,065 | $508,653 | $141,653 | $164,372 | $87,031 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 2,170 |
| Accounts payable and accrued liabilities | 19,659 | 34,935 | 32,578 | 26,784 | 18,473 |
| Accrued Expenses | 35,710 | N/A | N/A | N/A | N/A |
| Other current liabilities | 2,130 | 57,006 | 830 | 64 | 635 |
| TOTAL | $57,499 | $156,857 | $36,681 | $39,840 | $32,984 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 3,041 | 3,273 | 12,992 | 11,706 |
| Other Non-Current Liabilities | 256,530 | 201,905 | 5,520 | 682 | 15 |
| TOTAL | $289,119 | $214,380 | $21,036 | $18,614 | $30,941 |
| Total Liabilities | $346,618 | $371,237 | $57,717 | $58,454 | $63,925 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,890 | 14,149 | 14,118 | 13,889 | 13,386 |
| Common Shares | 239,961 | 221,124 | 211,266 | 203,511 | 191,343 |
| Retained earnings | 47,714 | -84,048 | -127,361 | -97,580 | -168,306 |
| Other shareholders' equity | -37 | -7 | 31 | -13 | 69 |
| TOTAL | $364,447 | $137,416 | $83,936 | $105,918 | $23,106 |
| Total Liabilities And Equity | $711,065 | $508,653 | $141,653 | $164,372 | $87,031 |